These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study. La Russa A; Cittadella R; De Marco EV; Valentino P; Andreoli V; Trecroci F; Latorre V; Gambardella A; Quattrone A J Neuroimmunol; 2010 Aug; 225(1-2):175-9. PubMed ID: 20471697 [TBL] [Abstract][Full Text] [Related]
8. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356 [TBL] [Abstract][Full Text] [Related]
9. MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques. Fiotti N; Altamura N; Fisicaro M; Carraro N; Adovasio R; Sarra VM; Uxa L; Guarnieri G; Baxter BT; Giansante C Atherosclerosis; 2005 Oct; 182(2):287-92. PubMed ID: 16159601 [TBL] [Abstract][Full Text] [Related]
10. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia. Djurić T; Zivković M; Stanković A; Dincić E; Raicević R; Alavantić D J Neurol Sci; 2008 Apr; 267(1-2):62-5. PubMed ID: 17942123 [TBL] [Abstract][Full Text] [Related]
11. MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS? Gašparović I; Čizmarević NS; Lovrečić L; Perković O; Lavtar P; Sepčić J; Jazbec SŠ; Kapović M; Peterlin B; Ristić S J Neuroimmunol; 2015 Sep; 286():13-5. PubMed ID: 26298319 [TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis. Zivković M; Djurić T; Dincić E; Raicević R; Alavantić D; Stanković A J Neuroimmunol; 2007 Sep; 189(1-2):147-50. PubMed ID: 17655938 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease. Fernandes KS; Brum DG; Sandrim VC; Guerreiro CT; Barreira AA; Tanus-Santos JE J Neuroimmunol; 2009 Sep; 214(1-2):128-31. PubMed ID: 19631393 [TBL] [Abstract][Full Text] [Related]
15. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis. Scalabrini D; Galimberti D; Fenoglio C; Comi C; De Riz M; Venturelli E; Castelli L; Piccio L; Ronzoni M; Lovati C; Mariani C; Monaco F; Bresolin N; Scarpini E Neurosci Lett; 2005 Nov; 388(3):149-52. PubMed ID: 16039046 [TBL] [Abstract][Full Text] [Related]
16. Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis. Nelissen I; Dubois B; Goris A; Ronsse I; Carton H; Opdenakker G J Neurol Sci; 2002 Aug; 200(1-2):43-8. PubMed ID: 12127674 [TBL] [Abstract][Full Text] [Related]
17. Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice. Fornoni A; Wang Y; Lenz O; Striker LJ; Striker GE J Am Soc Nephrol; 2002 Aug; 13(8):2068-76. PubMed ID: 12138138 [TBL] [Abstract][Full Text] [Related]
18. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults. Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217 [TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer. Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613 [TBL] [Abstract][Full Text] [Related]
20. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]